Indian Bulk Drugs : Market Research Report

Indian Bulk Drugs

Published by: Cygnus Business Consulting and Research

Published: Jul. 1, 2008 - 183 Pages

1. Executive Summary
2. Highlights
3. Global Bulk drugs Market --- Market Overview: 3.1. Introduction; 3.2 Global Bulk Drugs Market
4. Indian Bulk Drugs Market---- an Overview: 4.1 Indian Pharmaceutical Market; 4.2 Indian Bulk Drugs1; 4.3 Growth Trends; 4.4 Future outlook
5. Growth Drivers: 5.1 High Growth of Generics / Patent expiries; 5.2 New Drug Developments; 5.3 Contract Manufacturing; 5.4 Overall Pharmaceutical Growth; 5.5 Reduced Manufacturing cost
6. Industry Regulations 2: 6.1 Regulatory Bodies; 6.2 Pharmaceutical Policy-2002; 6.3 National pharmaceutical policy 2006; 6.4 Pricing of Scheduled Bulk Drugs; 6.5 Indian Patent law; 6.6 Labelling System in India; 6.7 Intellectual Property Rights (IPR); 6.8 Trade Related Aspects of Intellectual Property Rights (TRIPS); 6.9 Bulk drugs prices come under NPPA lens
7. Issues & Challenges: 7.1 Increasing Competition; 7.2 Coping with Changing Disease Profile; 7.3 Over Capacity; 7.4 Undifferentiated Capabilities; 7.5 Varying regulatory requirements lead to additional costs; 7.6 Threat from China
8. Major Players: 8.1 Aurobindo Pharma; 8.2 Ranbaxy Laboratories; 8.3 Dr. Reddy’s Laboratories; 8.4 Lupin Ltd; 8.5 Matrix Laboratories; 8.6 Cipla Ltd; 8.7 Orchid Chemicals and Pharmaceuticals Ltd.; 8.8 Divis laboratories; 8.9 Sun Pharmaceutical Industries Ltd; 8.10 Ipca Laboratories Ltd.; 8.11 Dishman Pharmaceutical and Chemicals Ltd; 8.12 Cadila Healthcare Ltd.112; 8.13 Alembic Ltd; 8.14. Glaxo SmithKline Pharmaceuticals Ltd.; 8.15 Glenmark Pharmaceuticals Ltd.; 8.16 Piramal Healthcare Limited (PHL); 8.17 Unichem Laboratories Ltd.; 8.18 Torrent Pharmaceuticals; 8.19 Merck India Ltd.; 8.20 Atul Ltd
9. Critical Success Factors: 9.1 Low- Cost Manufacturing Skills; 9.2 Striking Strategic Alliances (Mergers & Acquisitions); 9.3 Growing Experience with cGMP Compliance; 9.4 Complex Synthesis Capabilities; 9.5 Identifying New Opportunities Holds the Key for Generic Manufacturers.; 9.6 Indian Companies enter in to Global Cancer Drugs Market ......; 9.7 Focus on New therapeutic Segments; 9.8 Time the Market:; 9.9 Accreditations
10. Future Outlook
Annexure 1: List of Abbreviations
Annexure 2: DMF filings by Indian companies
Annexure 3: List of Bulk Drugs Manufacturers in India
Annexure 4: List of Industry Organizations
Annexure 5: Bibilography
LIST OF CHARTS: Chart 1: Global Pharmaceutical Market Value, 2002-2007; Chart 2: Market Share by Differentiation, 2007; Chart 3: Global Bulk Drugs Market Size, 2003-2007; Chart 4: Indian Pharmaceutical Market, 2002-2007; Chart 5: Major Therapeutic Segments, 2006-2007; Chart 6: Vision 2010: Glimpse of Indian Pharmaceutical Market Future; Chart 7: Estimated Indian Bulk Drugs Market; Chart 8: Indian Pharmaceutical Exports; Chart 9: Estimated Indian Bulk Drugs Exports; Chart 10: Estimated Indian Bulk Drugs Imports; Chart 11: Value of Patent Expiries, 2006-2010; Chart 12: Global Contract Manufacturing Market, 2002-2011; Chart 13: India & China DMF Filings; Chart 14: Estimated Indian Bulk Drugs Market, 2006-2010E; Chart 15: Estimated Indian Export and Import Trends, 2006-2010E
LIST OF TABLES: Table 1: Leading Therapeutic Segments, 2007; Table 2: Leading Brands, 2007; Table 3: Major Markets, 2007; Table 4: Market Segment; Table 5: Global Major players; Table 6: Global Mergers & Acquisition; Table 7: Annual Production of Major Bulk Drugs; Table 8: Mergers & Acquisition by Indian Companies; Table 9: ANDA Filings by Indian Companies; Table10: R&D Expenditure (2006-07); Table 11: DMF Filings by Indian Companies; Table 12: India’s Advantages for Contract Manufacturing; Table 13: Comparison between India and China

Abstract

Introduction
The Indian API (bulk drugs) manufacturing industry is estimated to have touched USD4.10 billion by 2007, growing at CAGR of 18.81% during 2003-07. India ranks fourth in terms of volume among the top 15 drug manufacturing countries. Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight to capture the present domestic market scenario, along with the major players and their key financials

Key Findings & Highlights

The global pharmaceutical market was valued at USD712 billion in 2007.
According to IMS Health, treatment costs per day declined by 20-40% in 2007 in therapy Areas
Generics continued to replace branded prescriptions in the major therapeutic classes, increasing their share of total dispensed prescriptions to 67.3 %.
In 2007, North America, which accounts for 45.9% of global pharmaceutical sales, grew by 4.2% to USD304.5 billion
The market size for the global bulk drugs was USD77.32 billion in 2005 and was estimated to be USD92.21 billion in 2007
Indian companies have the distinction of developing cost-effective technologies for manufacturing bulk drugs and intermediates that conform to global standards.

Reasons to Buy

Understand the global bulk drug market scenario
Know investment opportunities according to the trend analysis
Reveals the demand analysis of the bulk drugs industry
Assess the cost effective technologies for manufacturing bulk drugs

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Indian Bulk Drugs

Table of Contents

Abstract